Peer-reviewed publications by Yutaka Yonemura, M.D., Ph.D. (米村 豊), specialist in peritoneal surface oncology at Kishiwada Tokushukai Hospital. L-HIPEC papers are listed first within each section.
← Dr. Yonemura’s clinical page
Gastric Cancer
- Yonemura Y, Ishibashi H et al.
Effects of neoadjuvant laparoscopic HIPEC + NIPS on peritoneal metastases from gastric cancer.
Ann Surg Oncol 2017. · Kishiwada Tokushukai Hospital. · 53 patients. - Yu HH, Yonemura Y et al.
Neoadjuvant L-HIPEC + BISIC bidirectional chemotherapy for gastric cancer peritoneal metastases.
Cancers (Basel) 2023. · 113 patients. - Yonemura Y et al. (PSOGI)
Comprehensive treatment for gastric cancer peritoneal metastases with curative intent — PSOGI consensus.
Eur J Surg Oncol 2016. - Brandl A, Yonemura Y, Glehen O, Sugarbaker PH, Rau B.
Long-term survival (>5 years) after CRS + HIPEC for gastric peritoneal metastases — PSOGI multi-institutional cohort.
Eur J Surg Oncol 2021. - Prabhu A, Mishra D, Brandl A, Yonemura Y.
Gastric cancer with peritoneal metastases — comprehensive review of intraperitoneal treatment modalities.
Front Oncol 2022. - Yonemura Y, Liu Y, Sugarbaker PH, Li Y.
Current status and future prospects of clinical trials on CRS + HIPEC for gastric peritoneal metastases.
Int J Hyperthermia 2017.
Colorectal Cancer
- Arjona-Sánchez Á, Yonemura Y et al.
Laparoscopic CRS + HIPEC for limited peritoneal metastasis — PSOGI international registry (143 patients).
Eur J Surg Oncol 2021. · 88.2% disease-free. - Yonemura Y et al.
Prognostic factors after CRS + perioperative chemotherapy for colorectal peritoneal metastases — 142 patients.
Scientific World Journal 2013. · Open Access. - van de Vlasakker VCJ, … Yonemura Y, Glehen O et al.
Impact of PRODIGE 7 on CRS-HIPEC worldwide — PSOGI 2021 statement.
Eur J Surg Oncol 2021.
Ovarian Cancer
- Arjona-Sánchez Á, Yonemura Y et al.
Laparoscopic CRS + HIPEC — includes ovarian cancer cases (PSOGI international registry).
Eur J Surg Oncol 2021. - Canbay Torun B, … Yonemura Y et al.
Peritoneal metastasis of advanced epithelial ovarian carcinoma treated with CRS + HIPEC — international multicentric analysis.
Eur J Surg Oncol 2023.
Pseudomyxoma Peritonei & Appendiceal Cancer
- Arjona-Sánchez Á, Yonemura Y et al.
Laparoscopic CRS + HIPEC — pseudomyxoma peritonei is the most frequent indication (55% of 143 cases).
Eur J Surg Oncol 2021. · 88.2% disease-free. - Govaerts K, … Yonemura Y et al.
Appendiceal tumours and pseudomyxoma peritonei — PSOGI/EURACAN clinical practice guidelines.
Eur J Surg Oncol 2021.
Peritoneal Mesothelioma
- Arjona-Sánchez Á, Yonemura Y et al.
Laparoscopic CRS + HIPEC — includes multicystic mesothelioma (14% of PSOGI registry cases).
Eur J Surg Oncol 2021. - Kusamura S, … Yonemura Y et al.
Peritoneal mesothelioma — PSOGI/EURACAN clinical practice guidelines.
Eur J Surg Oncol 2021.
Pioneer & JASPSO
- Yonemura Y et al.
History of peritoneal surface malignancy treatment in Japan — JASPSO founding and global training programme.
PMC 2019. · JASPSO director · 16 international surgeons trained. - Yonemura Y, Ishibashi H et al.
Advances with pharmacotherapy for peritoneal metastasis.
Expert Opin Pharmacother 2020. · Kishiwada Tokushukai Hospital.
Data note
This list is compiled from publications provided by the department and may be updated periodically. Where available, items include direct links to PubMed, PMC, or journal pages.